Literature DB >> 19189635

The impact of enzymatic degradation on the uptake of differently sized therapeutic molecules.

Arne Erikson1, Ingunn Tufto, Anne Berit Bjønnum, Øyvind S Bruland, Catharina de Lange Davies.   

Abstract

BACKGROUND: The extracellular matrix represents a major barrier for drug delivery. This work compares the effects of collagenase and hyaluronidase on tumour uptake and distribution of two differently sized therapeutic molecules, IgG and liposomal doxorubicin.
MATERIALS AND METHODS: The enzymes were injected i.v. prior to the therapeutic molecules, and uptake and distribution were studied by confocal laser scanning microscopy. The therapeutic molecules were colocalized with the vasculature and collagen network visualized by the second harmonic signal.
RESULTS: Hyaluronidase increased the uptake of liposomal doxorubicin to a small extent, whereas collagenase had no effect. Collagenase increased, but hyaluronidase reduced the uptake of IgG. Neither of the enzymes induced changes in the collagen network measured by the second harmonic signal.
CONCLUSION: Degradation of the collagen network improves delivery of molecules with the size of IgG, whereas degradation of the gel of glycosaminoglycans has a higher impact on the distribution of small drugs such as doxorubicin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19189635

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

Review 1.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

2.  Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment.

Authors:  Kenji Yokoi; Milos Kojic; Miljan Milosevic; Tomonori Tanei; Mauro Ferrari; Arturas Ziemys
Journal:  Cancer Res       Date:  2014-05-22       Impact factor: 12.701

Review 3.  Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.

Authors:  Yinghuan Li; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Journal:  Adv Drug Deliv Rev       Date:  2011-05-03       Impact factor: 15.470

4.  Characterization of tumor microvascular structure and permeability: comparison between magnetic resonance imaging and intravital confocal imaging.

Authors:  Nina Kristine Reitan; Marte Thuen; Pål Erik Goa; Catharina de Lange Davies
Journal:  J Biomed Opt       Date:  2010 May-Jun       Impact factor: 3.170

5.  Nanoparticles functionalized with collagenase exhibit improved tumor accumulation in a murine xenograft model.

Authors:  Surya Murty; Taylor Gilliland; Peter Qiao; Tate Tabtieng; Elizabeth Higbee; Ajlan Al Zaki; Ellen Puré; Andrew Tsourkas
Journal:  Part Part Syst Charact       Date:  2014-12       Impact factor: 3.310

Review 6.  Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery.

Authors:  Aaron Dolor; Francis C Szoka
Journal:  Mol Pharm       Date:  2018-05-16       Impact factor: 4.939

7.  Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier.

Authors:  Kenji Yokoi; Diana Chan; Milos Kojic; Miljan Milosevic; David Engler; Rise Matsunami; Tomonori Tanei; Yuki Saito; Mauro Ferrari; Arturas Ziemys
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

8.  Periodicity in tumor vasculature targeting kinetics of ligand-functionalized nanoparticles studied by dynamic contrast enhanced magnetic resonance imaging and intravital microscopy.

Authors:  Sjoerd Hak; Jana Cebulla; Else Marie Huuse; Catharina de L Davies; Willem J M Mulder; Henrik B W Larsson; Olav Haraldseth
Journal:  Angiogenesis       Date:  2013-08-27       Impact factor: 9.596

9.  Near-infrared fluorescence energy transfer imaging of nanoparticle accumulation and dissociation kinetics in tumor-bearing mice.

Authors:  Yiming Zhao; Inge van Rooy; Sjoerd Hak; Francois Fay; Jun Tang; Catharina de Lange Davies; Mihaela Skobe; Edward Allen Fisher; Aurelian Radu; Zahi A Fayad; Celso de Mello Donegá; Andries Meijerink; Willem J M Mulder
Journal:  ACS Nano       Date:  2013-10-24       Impact factor: 15.881

10.  Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments.

Authors:  Kenji Yokoi; Tomonori Tanei; Biana Godin; Anne L van de Ven; Masaki Hanibuchi; Aika Matsunoki; Jenolyn Alexander; Mauro Ferrari
Journal:  Cancer Lett       Date:  2013-12-24       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.